Biostar Pharmaceuticals, Inc.
BSPM
Get informed when a big investor buys or sells
+ FollowMarket Cap$264
Close$
Share Statistics
| Market cap | $264.00 |
|---|---|
| Enterprise Value | $2.06 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.5 |
| Beta | -163.62 |
| Outstanding Shares | 2,503,000 |
Return
| Return on Equity | 0.87% |
|---|---|
| Return on Assets | 0.76% |
| Return on Invested Capital | 9.85% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 6.49 |
| Enterprise Value to EBIT | 0.58 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 1.18 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Biostar Pharmaceuticals, Inc.
200 employees
CEO: Mr. Ronghua Wang Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin A...